- ￥1560
- biorbyt
- orb256522
- 英国
- 2025年12月05日
- IF, IHC, WB
- Rabbit
- Human, Mouse, Rat
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
HER4 Antibody抗体
- 抗体英文名：
HER4 Antibody
- 应用范围：
IF, IHC, WB
- 宿主：
Rabbit
- 适应物种：
Human, Mouse, Rat
- 保质期：
6-12个月
- 抗原来源：
详询
- 目录编号：
orb256522
- 级别：
科研级
- 库存：
88
- 供应商：
biorbyt
- 标记物：
Unconjugated
- 克隆性：
Polyclonal
- 形态：
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
- 免疫原：
KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human HER4. The exact sequence is proprietary.
- 规格：
30 ul
别名:HER4; Receptor tyrosine-protein kinase erbB-4; Proto-oncogene-like protein c-ErbB-4; Tyrosine kinase-type cell surface receptor HER4; p180erbB4
免疫原：KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human HER4. The exact sequence is proprietary.
应用稀释比例：WB: 1:500-1000, IHC-P: 1:100-200, IF/ICC: 1:100-500
纯化:The antibody was purified by immunogen affinity chromatography.
保存说明:Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Entrez:59323, 2066, 13869
UniProt ID:Q62956, Q61527, Q15303
Note:For research use only.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Detection of ErbB Receptor Family Tyrosyl Phosphorylation in Ovarian Carcinoma Cells
-3), and HER4 (ErbB-4). These receptors share a common molecular architecture, possessing a large glycosylated extracellular ligand-binding domain, a single hydrophobic transmembrane domain, and a cytoplasmic tyrosine kinase domain (2 ). Amplification
Immunohistochemical Determination of EGFR-Tyrosine Kinase Inhibition in Clinical Samples
The epidermal growth factor receptor (EGFR) family consists of four closely related transmembrane receptors including the EGFR (erbB1), erbB2 (HER2), erbB3 (HER3), and erbB4 (HER4). EGFR (erbB1) was the first member to be described
ERBB4 Mutation Analysis: Emerging Molecular Target for Melanoma Treatment
is the ERBB4 receptor, or HER4, a member of the Erb receptor family, which has recently been shown to be a major oncogenic “driver” in melanoma. Mutated ERBB4 signaling activates both aberrant ERBB4 and PI3K-AKT signal transduction, mediates sensitivity
技术资料暂无技术资料 索取技术资料
